Publications

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.

Andersson TM, Crowther MJ, Czene K, Hall P, Humphreys K. Am J Epidemiol. 2017 Nov 1;186(9):1065-1073. doi: 10.1093/aje/kwx178....


No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, et al.  J Med Genet. 2016 Feb 26. pii: jmedgenet-2015-103529. ...


Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. 

Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.  Breast Cancer Res. 2016 Oct 5;18(1):100. PMID: 27716311...


PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. 

Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, et al.  J Med Genet. 2016 Sep 5. pii: jmedgenet-2016-103...


Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium. 

Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, et al.  Breast Cancer Res. 2016 Oct 3;18(1):98. PMID...


PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1.

Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, et al. Oncotarget. 2017 Oct 12;8(61):102769-102782. doi: 10.1863...


Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry.

Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, et al. Breast Cancer Res. 2016 Dec 8;18(1):124....


RAD51B in Familial Breast Cancer. 

Pelttari LM, Khan S, Vuorela M, Kiiski JI, Vilske S, Nevanlinna V, Ranta S, Schleutker J, et al.  PLoS One. 2016 May 5;11(5):e0153788. doi: 10.1371/j...


Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, Wildiers H, et al. Breast Cancer Res. 2017 Nov 7;19(1):119. doi: 10.1186/s13...


Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study.

Yang H, Brand JS, Li J, Ludvigsson JF, Ugalde-Morales E, Chiesa F, Hall P, Czene K. BMC Med. 2017 Aug 11;15(1):154. doi: 10.1186/s12916-017-0915-4....


Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Colzani E, Clements M, Johansson AL, Liljegren A, He W, Brand J, Adolfsson J, Fornander T, Hall P, Czene K. . Br J Cancer. 2016 Oct 4. doi: 10.1038...


rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al. Sci Rep. 2016 Nov 15;6:36874. doi: 10.1038/srep36874....


SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. 

Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, et al.  Oncotarget. 2015 Jul 22. [Epub ahead of print]...


Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.  Cancer. 2016 Oct 11. doi: 10.1002/cncr.30364. PMID: 27727...


Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.

Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K. Int J Cancer. 2017 Feb 15;140(4):841-852. doi: 10.1002/ijc.30514. Epub 2016 Nov 25....


TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al. Oncotarget. 2017 Mar 14;8(11):18381-18398. do...


Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.

He W, Smedby KE, Fang F, Olsson H, Margolin S, Hall P, Czene K. J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx041....


Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study. 

Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, Czene K.  Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30370. PMID: 27486698...